The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

TD Cowen analyst Tyler Van Buren has maintained their neutral stance on MRNA stock, giving a Hold rating on October 17. Tyler Van ...

TD Cowen维持对Moderna股票(NASDAQ: MRNA)的"持有"评级，目标价保持在60.00美元不变。 该公司在生物科技板块第三季度财报预览前发布了这一更新，并对Moderna的财务模型进行了调整。

The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, ...

Oct. 21—The Cleburne Railroaders on Monday announced the release of their 2025 season schedule, highlighted by an exciting Opening Day showdown on May 8 against the Winnipeg Goldeyes at La Moderna ...

A new study by researchers at Zhejiang University has highlighted the disproportionate health challenges faced by sexual and ...

疫苗制造商Novavax (NVAX)股价经历了一年的过山车式波动。5月，该公司宣布与生物科技巨头赛诺菲达成一项利润丰厚的协议后，股价飙升。自那以后，Novavax的股价一直在走下坡路，不过这可能是由于一些投资者获利回吐。

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

Vertex Pharmaceuticals dominates the cystic fibrosis market with a promising pipeline and strategic M&A activity. Read why I ...